Proteogenomic analysis of human pancreatic ductal adenocarcinoma

No authors listed

Comment

No authors listed. Nat Cancer. 2023 Feb.

. 2023 Feb;4(2):163-164.

doi: 10.1038/s43018-022-00478-8.

No abstract available

Comment on

Proteogenomic landscape of human pancreatic ductal adenocarcinoma in an Asian population reveals tumor cell-enriched and immune-rich subtypes.
Hyeon DY, Nam D, Han Y, Kim DK, Kim G, Kim D, Bae J, Back S, Mun DG, Madar IH, Lee H, Kim SJ, Kim H, Hyun S, Kim CR, Choi SA, Kim YR, Jeong J, Jeon S, Choo YW, Lee KB, Kwon W, Choi S, Goo T, Park T, Suh YA, Kim H, Ku JL, Kim MS, Paek E, Park D, Jung K, Baek SH, Jang JY, Hwang D, Lee SW. Hyeon DY, et al. Nat Cancer. 2023 Feb;4(2):290-307. doi: 10.1038/s43018-022-00479-7. Epub 2022 Dec 22. Nat Cancer. 2023. PMID: 36550235

1. Collison, E. A. et al. Molecular subtypes of pancreatic cancer. Nat. Rev. Gastroenterol. Hepatol. 16, 207–220 (2019). This review article presents diverse molecular subtypes of pancreatic cancer. - DOI
1. Cancer Genome Atlas Research Network. Integrated genomic characterization of pancreatic ductal adenocarcinoma. Cancer Cell 32, 185–203 (2017). This paper reports an analysis of PDAC with integrated genomics. - DOI
1. Waddel, N. et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature 518, 495–501 (2015). This paper reports an analysis of whole genomes to identify mutations in pancreatic cancer. - DOI
1. Bailey, P. et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature 531, 47–52 (2016). This paper reports the genomic analyses of PDAC subtypes. - DOI - PubMed
1. Cao, L. et al. Proteogenomic characterization of pancreatic ductal adenocarcinoma. Cell 184, 5031–5052 (2021). This paper reports the proteogenomic analysis of PDAC by the Clinical Proteogenomic Tumor Analysis Consortium. - DOI - PubMed - PMC